NDAQ:SIGA - Post Discussion
Post by
AviseAnalytics on May 26, 2022 7:53am
SIGA’S SMALLPOX WIN IS NO MONKEY BUSINESS!
$SIGA
Siga Technologies (NASDAQ: SIGA), a commercial-stage pharmaceutical company scored an FDA approval for its intravenous (IV) formulation of TPOXX® (tecovirimat) by the U.S. Food and Drug Administration (FDA). Given the rise of Monkeypox cases around the globe, can the Company leverage its expertise to make the most of the emerging opportunity?
https://www.aviseanalytics.com/sigas-smallpox-win-is-no-monkey-business/
Be the first to comment on this post